SC 13D

Company

Corvus Pharmaceuticals, Inc.

Filed

March 21, 2018

Accession Number

0001144204-18-016167

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →